If you need more lookups,
subscriptions start at $34 USD/month.
Christophe Quéva Location
Cambridge, MA, US
Christophe Quéva Work
Board Member and Chief Scientific Officer @ (September 2025 - Present)
Senior Scientific Advisor @ (May 2021 - Present)
President and Chief Executive Officer @ (January 2025 - August 2025)
Co-Founder, President and Chief Executive Officer @ Ovie Therapeutics (February 2024 - January 2025)
Chief Scientific Officer @ (September 2022 - November 2024)
Scientific Advisory Board member @ (July 2021 - September 2022)
Chief Scientific Officer @ (October 2017 - September 2022)
Chief Scientific Officer @ (August 2015 - September 2017)
Director Biology, Translational Medicine @ (May 2015 - July 2015)
Director of Biology, Oncology and Inflammation @ (June 2012 - April 2015)
Consultant @ Scientific and strategic consulting (January 2012 - June 2012)
Director Research, Hematology Oncology Therapeutic Area @ (September 2006 - December 2011)
Associate director @ (September 2001 - September 2006)
Associate director @ (May 1998 - September 2001)
Post-doctoral fellow @ (February 1993 - May 1998)
PhD @ Institut Pasteur de Lille (July 1989 - February 1993)
Christophe Quéva Education
University of Lille 1 Sciences and Technology
PhD (Health sciences)
1989-1993
Harvard Business School Executive Education
Executive Program, Preparing to be a corporate director (Preparing to be a corporate director)
2026
Christophe Quéva Skills
Drug Discovery
Pharmacology
Biomarkers
Immunology
Oncology
Antibodies
Small Molecules
Animal Models
Cancer
Assay Development
Validation
Biologics
Translational Research
Inflammation
Clinical Development
Biomarker Discovery
Lead Change
In Vivo
Target Selection
Biotechnology
Drug Development
Cell
Monoclonal Antibodies
Antibody therapeutics
PK-PD relationship
Inter-personal
Immunohistochemistry
Science
Biopharmaceuticals
Protein Chemistry
Lifesciences
Regulatory Submissions
Life Sciences
Pk Pd Relationship
Inter Personal
Initiation
Microsoft Office
Treatment
Research
Oversight
Customer Service
Clinical Research
Strategic Planning
Immunoassays
Christophe Quéva Summary
Christophe Quéva, based in Cambridge, MA, US, is currently a Board Member and Chief Scientific Officer at Triptych Therapeutics. Christophe Quéva brings experience from previous roles at Bpifrance, Egle Therapeutics, Ovie Therapeutics and DEM Biopharma, Inc.. Christophe Quéva holds a 1989 - 1993 PhD in Health sciences @ University of Lille 1 Sciences and Technology. With a robust skill set that includes Drug Discovery, Pharmacology, Biomarkers, Immunology, Oncology and more. Christophe Quéva has 2 emails on RocketReach.
Looking for a different Christophe Quéva?
Find contact details for 700 million professionals.